Becton, Dickinson and Company BDX

Full chart Compare
Set alert

Price alert · BDX

All alert types
209.19 USD +11.02 (+5.56%)

At closeNov 4, 2026, 5:11 PM EST

209.05 -0.14 -0.07%

After hours · Nov 4, 5:11 PM ET

200.30 Day range 209.84
127.59 52-week range 209.84
YTD
+37.11%
1 year
+48.63%

Revenue & Expenses

Revenue by
Medical → Revenue: $11.46BRevenue → Gross Profit: $9.92BGross Profit → Net Income: $1.68BGross Profit → Selling, General & Admin: $5.28BGross Profit → Research & Development: $1.26BRevenue → Cost of Revenue: $11.91BGross Profit → Other Operating Expenses: $806.00MGross Profit → Interest Expense: $613.00MGross Profit → Other Expenses: $82.00MGross Profit → Income Tax: $204.00MInterventional → Revenue: $5.22BLife Sciences → Revenue: $5.17BGross Profit$9.92BCost of Revenue$11.91BNet Income$1.68BSelling, General & Admin$5.28BResearch & Development$1.26BOther Operating Expenses$806.00MInterest Expense$613.00MOther Expenses$82.00MIncome Tax$204.00MRevenue$21.84BMedical$11.46BInterventional$5.22BLife Sciences$5.17B

Latest period ending Sep 30, 2025 · select a line to chart its full history

BDX annual income statement
Fiscal yearFY 2025 Sep 30, 2025FY 2024 Sep 30, 2024FY 2023 Sep 30, 2023FY 2022 Sep 30, 2022FY 2021 Sep 30, 2021
21.84B20.18B19.37B18.87B19.13B
9.93B9.13B8.17B8.48B8.63B
2.58B2.40B2.11B2.28B2.25B
1.68B1.71B1.48B1.78B2.09B
5.825.864.945.886.85
BDX annual balance sheet
Fiscal yearFY 2025 Sep 30, 2025FY 2024 Sep 30, 2024FY 2023 Sep 30, 2023FY 2022 Sep 30, 2022FY 2021 Sep 30, 2021
777.00M1.86B1.48B1.16B2.39B
55.33B57.29B52.78B52.93B53.87B
29.93B31.40B26.98B27.65B30.19B
19.18B20.11B15.88B16.07B17.61B
25.39B25.89B25.80B25.28B23.68B
BDX annual cash flow
Fiscal yearFY 2025 Sep 30, 2025FY 2024 Sep 30, 2024FY 2023 Sep 30, 2023FY 2022 Sep 30, 2022FY 2021 Sep 30, 2021
3.43B3.80B2.99B2.63B4.65B
-818.00M-5.51B-716.00M-3.23B-1.88B
-3.62B2.09B-1.96B-591.00M-3.31B
-760.00M-725.00M-874.00M-973.00M-1.19B
-1.00B375.00M322.00M-1.23B-525.00M